Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver
- PMID: 19635229
- DOI: 10.6004/jnccn.2009.0053
Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver
Abstract
Management of liver metastasis from neuroendocrine tumors routinely includes an interventional radiologist. Hepatic artery embolization, either bland (transarterial embolization) or with chemotherapy (transarterial chemoembolization), has been shown to improve response rates in neuroendocrine metastases to the liver. Radiofrequency ablation, cryotherapy, and percutaneous alcohol ablation are important adjuncts or alternative treatments to surgical debulking. In this article, the authors examine important techniques in the armamentarium of the interventional radiologist.
Similar articles
-
Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases.World J Surg. 2001 Jun;25(6):693-6. doi: 10.1007/s00268-001-0015-6. World J Surg. 2001. PMID: 11376399
-
Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.Cardiovasc Intervent Radiol. 2005 Jul-Aug;28(4):409-21. doi: 10.1007/s00270-004-4082-6. Cardiovasc Intervent Radiol. 2005. PMID: 16041556 Review.
-
Update on the management of neuroendocrine hepatic metastases.J Vasc Interv Radiol. 2006 Aug;17(8):1235-49; quiz 1250. doi: 10.1097/01.RVI.0000232177.57950.71. J Vasc Interv Radiol. 2006. PMID: 16923972 Review.
-
[Liver chemoembolization: an update].Bull Cancer. 2009 Nov;96(11):1111-6. doi: 10.1684/bdc.2009.0972. Bull Cancer. 2009. PMID: 19864205 French.
-
Management of advanced neuroendocrine tumors with hepatic metastasis.J Clin Gastroenterol. 2009 Oct;43(9):838-47. doi: 10.1097/MCG.0b013e3181b152a1. J Clin Gastroenterol. 2009. PMID: 19654558 Review.
Cited by
-
A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors.Ann Oncol. 2012 Sep;23(9):2335-2341. doi: 10.1093/annonc/mdr614. Epub 2012 Feb 8. Ann Oncol. 2012. PMID: 22317769 Free PMC article. Clinical Trial.
-
Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?BMC Cancer. 2017 Feb 23;17(1):154. doi: 10.1186/s12885-017-3150-7. BMC Cancer. 2017. PMID: 28231773 Free PMC article.
-
Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.J Gastroenterol. 2012 Sep;47(9):941-60. doi: 10.1007/s00535-012-0642-8. Epub 2012 Aug 11. J Gastroenterol. 2012. PMID: 22886480 Free PMC article. Review.
-
Multimodal liver-directed management of neuroendocrine hepatic metastases.Int J Hepatol. 2011;2011:452343. doi: 10.4061/2011/452343. Epub 2011 Oct 29. Int J Hepatol. 2011. PMID: 22121491 Free PMC article.
-
Pancreatic neuroendocrine tumors.Indian J Gastroenterol. 2013 Jan;32(1):3-17. doi: 10.1007/s12664-012-0257-2. Epub 2012 Oct 3. Indian J Gastroenterol. 2013. PMID: 23054950 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical